Lv6
1870 积分 2024-07-01 加入
A Tale of Two Diseases
1小时前
待确认
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1小时前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
11天前
已完结
Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double‐blind, placebo‐controlled trial
21天前
已完结
AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease
21天前
已完结
Targeting Lipoprotein(a) — the Next Frontier in Cardiovascular Disease
23天前
已完结
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
1个月前
已完结
Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial
1个月前
已完结
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
1个月前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2个月前
已完结
皖公网安备34019202002308
